Part-time | Roden| MBO Over het bedrijf PureIMS B.V. | Ceintuurbaan Noord 152 | 9301 NZ Roden PureIMS, gevestigd in Roden, ontwikkelt Droog Poeder Inhalatoren (DPIs) voor de behandeling van verschillende systemische en pulmonaire aandoeningen. Met regelmaat worden DPIs geproduceerd voor een vaste groep patiënten in Nederland. Deze DPIs worden geproduceerd op de productielocatie van PureIMS onder de daarvoor […]
PureIMS secures new investment round to develop lead inhalation product and facilitate partnering activities
PureIMS today announced it has secured a new investment round. New investor Boost-UP Foundation has joined current shareholders (CardusoCapital venture capital fund, IMDS Medical Devices and LinesBridge Pharma Group) in this round to finance the company’s ambitious growth strategy. Please find the full press release via this link:
PureIMS names Frank Lambert to advance commercialization of its Cyclops™ Dry Powder Inhaler (DPI)
Roden — February 10, 2023 — PureIMS, a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies for systemic and respiratory diseases, has appointed Frank Lambert to the role of Executive Director Commercialization. DPI developer PureIMS has announced the appointment of Frank Lambert as Executive Director Commercialization. The appointment is part of the […]
Fysisch-chemisch analist
Full time | Groningen, Roden| MBO/HBO | > 1-5 jaar ervaring | Over het bedrijf PureIMS B.V. | Ceintuurbaan Noord 152 | 9301 NZ Roden PureIMS is gespecialiseerd in het geschikt maken van geneesmiddelen voor toediening via de longen. De geneesmiddelen worden met behulp van innovatieve droogpoederinhalatoren toegediend. Successen worden behaald op het gebied van […]
Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™
Check out our scientific poster for DDL2022 on Epinephrine Cyclops™!
PureIMS present at DDL2022
PureIMS will be present at the Drug Delivery to the Lungs Conference 2022 in Edinburgh. Please visit our stand (246) and have a chat. We will be more than happy to tell you everything about our Cyclops™ single-use dry powder inhaler and hear all about your interesting projects too! Furthermore, check out our posters on […]
PureIMS appoints Jaap Wieling, PhD, as new CEO
Roden — January 7, 2022 — PureIMS, a clinical stage pharmaceutical and medication systems company focused on developing and commercializing innovative inhaled therapies for systemic and respiratory diseases has appointed Jaap Wieling to the role of Chief Executive Officer (CEO). Dr. Wieling brings 30 years of experience as an executive and entrepreneur in (bio)pharmaceutical research […]
Levodopa Cyclops™ in Dutch magazine ‘Tijdschrift voor Neurologie en Neurochirurgie (TNN)’
Inhaled levodopa for the rescue treatment of OFF episodes in Parkinson’s disease OFF episodes are an unmet medical need with a great impact on the quality of life of Parkinson’s disease patients. Oral levodopa does not prevent the occurrence of OFF episodes, nor enables their fast resolve, mainly because of a highly variable and unreliable […]
PureIMS participating in Biotech Showcase™ 2022
PureIMS aims to find a partner for its lead program Levodopa Cyclops™ Roden — December 22, 2021 — PureIMS today announced that it is participating in Biotech Showcase™ 2022. PureIMS is a clinical stage pharmaceutical and medication systems company developing a portfolio of products addressing acute and unmet medical needs. These products are based on […]
Towards a cure for Mycobacterium abscessus disease using inhaled tigecycline
Roden — July 7, 2021 — Mycobacterium abscessus is a nontuberculous mycobacterium (NTM) that primarily causes severe pulmonary infections. The pathogen is also known as the ‘antibiotic nightmare’, due to its resistance to nearly all antibiotics. Following successful research into a potential treatment option, PureIMS, Radboudumc and Sever Pharma Solutions (until recently known as Disphar […]